TIL
Instil Bio (TIL)
$56
About Instil Bio (TIL)
Instil Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Details
Daily high
$7.89
Daily low
$7.56
Price at open
--
52 Week High
$33.83
52 Week Low
$5.67
Market cap
51.3M
Dividend yield
0.00%
Volume
18
Avg. volume
18,200
P/E ratio
-1.07
Instil Bio News
Details
Daily high
$7.89
Daily low
$7.56
Price at open
--
52 Week High
$33.83
52 Week Low
$5.67
Market cap
51.3M
Dividend yield
0.00%
Volume
18
Avg. volume
18,200
P/E ratio
-1.07